| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Natalizumab | LP64671-8 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser | LP7567-3 |
| SCALE_TYP | Ord | LP7751-3 |
| METHOD_TYP | IA | LP217197-5 |
| parent | Lab terms not yet categorized | LP248770-2 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | ug/mL | |
| EXAMPLE_UCUM_UNITS | ug/mL | |
| UNITSREQUIRED | N | |
| STATUS | ACTIVE |
| LONG_COMMON_NAME | en-US | Natalizumab [Mass/volume] in Serum by Immunoassay |
| LONG_COMMON_NAME | en-US | Natalizumab [Mass/volume] in Serum by Immunoassay |
| SHORTNAME | en-US | Natalizumab Ser Ql IA |
| ConsumerName | en-US | Natalizumab, Blood |
| LONG_COMMON_NAME | nl-NL | Natalizumab [massa/volume] in serum d.m.v. immunoassay |
LOINC Version: 2.81
FHIR